Hofmann, Stefan G.Carpenter, Joseph K.Otto, Michael W.Rosenfield, DavidSmits, Jasper A. J.Pollack, Mark H.2018-02-052018-02-052015-07Stefan G Hofmann, Joseph K Carpenter, Michael W Otto, David Rosenfield, Jasper AJ Smits, Mark H Pollack. 2015. "Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.." Contemp Clin Trials, Volume 43, pp. 223 - 230.1559-2030https://hdl.handle.net/2144/26681The use of D-cycloserine (DCS) as a cognitive enhancer to augment exposure-based cognitive-behavioral therapy (CBT) represents a promising new translational research direction with the goal to accelerate and optimize treatment response for anxiety disorders. Some studies suggest that DCS may not only augment extinction learning but could also facilitate fear memory reconsolidation. Therefore, the effect of DCS may depend on fear levels reported at the end of exposure sessions. This paper presents the rationale and design for a randomized controlled trial examining the relative efficacy of tailoring DCS administration based on exposure success (i.e. end fear levels) during a 5-session group CBT protocol for social anxiety disorder (n = 156). Specifically, tailored post-session DCS administration will be compared against untailored post-session DCS, untailored pre-session DCS, and pill placebo in terms of reduction in social anxiety symptoms and responder status. In addition, a subset of participants (n = 96) will undergo a fear extinction retention experiment prior to the clinical trial in which they will be randomly assigned to receive either DCS or placebo prior to extinguishing a conditioned fear. The results from this experimental paradigm will clarify the mechanism of the effects of DCS on exposure procedures. This study aims to serve as the first step toward developing an algorithm for the personalized use of DCS during CBT for social anxiety disorder, with the ultimate goal of optimizing treatment outcome for anxiety disorders.p. 223 - 230Life sciences & biomedicineMedicine, research & experimentalPharmacology & pharmacyResearch & experimental medicineCognitive-behavioral therapyExposure therapyD-cycloserineSocial anxiety disorderSocial phobiaRandomized controlled trialPost traumatic stress disorderExposure therapyFearPhobiaDepressionAnxiety disordersCombined modality therapyCycloserineDouble-blind methodHeart rateHumansHydrocortisoneImplosive therapyPsychiatric status rating scalesResearch designSalivaSeverity of illness indexSleepMedical and health sciencesGeneral clinical medicinePublic healthArticle10.1016/j.cct.2015.06.0150000-0002-3548-9681 (Hofmann, Stefan G)